Invesco’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-48,409
| Closed | -$4.12M | – | 3881 |
|
|
2020
Q3 | $4.12M | Sell |
48,409
-1,738,187
| -97% | -$87.9M | ﹤0.01% | 2101 |
|
|
2020
Q2 | $63.3M | Buy |
1,786,596
+1,241,631
| +228% | +$36.3M | 0.02% | 799 |
|
|
2020
Q1 | $7.35M | Buy |
544,965
+28,373
| +5% | +$477K | ﹤0.01% | 1675 |
|
|
2019
Q4 | $10.9M | Sell |
516,592
-31,225
| -6% | -$551K | ﹤0.01% | 1709 |
|
|
2019
Q3 | $7.26M | Hold |
547,817
| – | – | ﹤0.01% | 1907 |
|
|
2019
Q2 | $7.6M | Buy |
547,817
+62,967
| +13% | +$947K | ﹤0.01% | 1926 |
|
|
2019
Q1 | $9.31M | Buy |
+484,850
| New | +$7.81M | ﹤0.01% | 1617 |
|
|
2018
Q4 | – | Sell |
-734,673
| Closed | -$15.3M | – | 3913 |
|
|
2018
Q3 | $15.3M | Buy |
734,673
+289,122
| +65% | +$6.85M | ﹤0.01% | 1457 |
|
|
2018
Q2 | $10.5M | Buy |
445,551
+121,370
| +37% | +$2.44M | ﹤0.01% | 1630 |
|
|
2018
Q1 | $4.74M | Sell |
324,181
-224,762
| -41% | -$3.67M | ﹤0.01% | 1997 |
|
|
2017
Q4 | $8.87M | Sell |
548,943
-76,459
| -12% | -$902K | ﹤0.01% | 1636 |
|
|
2017
Q3 | $8.74M | Buy |
625,402
+263,795
| +73% | +$2.63M | ﹤0.01% | 1640 |
|
|
2017
Q2 | $3.19M | Buy |
+361,607
| New | +$2.54M | ﹤0.01% | 2224 |
|
|
2015
Q3 | – | Sell |
-1,242
| Closed | -$5K | – | 4109 |
|
|
2015
Q2 | $5K | Buy |
+1,242
| New | +$5.08K | ﹤0.01% | 4246 |
|
Invesco's IMMU Position: Q4 2020 in Review
Invesco sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 48,409 shares — an estimated $4.12M sold.
Invesco first reported a position in IMMU in Q2 2015 and held it in 14 quarters. The position peaked at $63.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Invesco reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Invesco sold 48,409 Immunomedics Inc shares in Q4 2020, an estimated $4.12M.
- Invesco first reported a position in Immunomedics Inc in Q2 2015 and held it in 14 quarters.
- Invesco's Immunomedics Inc position peaked at $63.3M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Invesco's 13F filing for Q4 2020, filed 16 Feb 2021.